Combinations of TAPBP mRNA i-expression and tapasin-dependence levels were associated with both blood-stage parasitemia and clinical malaria, both of which are influenced by liver-stage immunity, but these variants had no impact on parasite density, an outcome determined at the blood stage of disease. Here, TAPBP is linked to malaria.